Detalles de la búsqueda
1.
Formic acid as an alternative reducing agent for the catalytic nitrate reduction in aqueous media.
J Environ Sci (China)
; 25(8): 1696-702, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24520710
2.
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors: part II.
Bioorg Med Chem Lett
; 22(12): 4189-92, 2012 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22578459
3.
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors.
Bioorg Med Chem Lett
; 21(4): 1218-21, 2011 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21256006
4.
Property based optimization of δ-lactam HDAC inhibitors for metabolic stability.
Bioorg Med Chem Lett
; 20(22): 6808-11, 2010 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20850971
5.
Structure based optimization of chromen-based TNF-α converting enzyme (TACE) inhibitors on S1' pocket and their quantitative structure-activity relationship (QSAR) study.
Bioorg Med Chem
; 18(24): 8618-29, 2010 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21078557
6.
Discovery of Orally Available Runt-Related Transcription Factor 3 (RUNX3) Modulators for Anticancer Chemotherapy by Epigenetic Activation and Protein Stabilization.
J Med Chem
; 58(8): 3512-21, 2015 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25811792
7.
Development of a novel class of mitochondrial ubiquinol-cytochrome c reductase binding protein (UQCRB) modulators as promising antiangiogenic leads.
J Med Chem
; 57(19): 7990-8, 2014 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25244355
8.
Lactam-based HDAC inhibitors for anticancer chemotherapy: restoration of RUNX3 by posttranslational modification and epigenetic control.
ChemMedChem
; 9(3): 649-56, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24376239
9.
Discovery of pyridone-based histone deacetylase inhibitors: approaches for metabolic stability.
ChemMedChem
; 8(2): 272-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23292995
10.
Property-based optimization of hydroxamate-based γ-lactam HDAC inhibitors to improve their metabolic stability and pharmacokinetic profiles.
J Med Chem
; 55(23): 10766-70, 2012 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23163332
Resultados
1 -
10
de 10
1
Próxima >
>>